CVE-2015-3956
3Vexday Risk Score
No sign of exploitation. No public exploitation artifact known so far.
ssvc Trackepss 1.0%
exploitation probability
1.0%top 42% of all CVEs
observed exploitation
nono source reports it
Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Infusion System version 13.6 and prior, and Symbiq Infusion System, version 3.13 and prior accept drug libraries, firmware updates, pump commands, and unauthorized configuration changes from unauthenticated devices on the host network. Hospira recommends that customers close Port 20/FTP and Port 23/TELNET on the affected devices. Hospira has also released the Plum 360 Infusion System which is not vulnerable to this issue.